SCHEDULE 13G: FMR LLC and Abigail P. Johnson Disclose 14.7% Stake in Jade Biosciences Inc.
Beneficial Ownership Report
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have disclosed a significant beneficial ownership stake of 14.7% in Jade Biosciences Inc., totaling 4,735,951 common shares.
Summary
- FMR LLC, a parent holding company, and Abigail P. Johnson, its Chairman and CEO, have filed a Schedule 13G disclosing their beneficial ownership in JADE BIOSCIENCES INC.
- As of May 30, 2025, FMR LLC and Abigail P. Johnson collectively beneficially own 4,735,951 shares of JADE BIOSCIENCES INC common stock.
- This ownership represents 14.7% of the total outstanding common stock of JADE BIOSCIENCES INC.
- FMR LLC holds sole voting power over 4,733,347 shares and sole dispositive power over 4,735,951 shares.
- Abigail P. Johnson holds sole dispositive power over 4,735,951 shares, with no sole or shared voting power.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Entities within FMR LLC, including Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, and Fidelity Management Trust Company, are involved in the beneficial ownership, with Fidelity Management & Research Company LLC noted as beneficially owning 5% or greater of the outstanding shares.
Sentiment
Score: 6
Explanation: The disclosure of a significant stake by a reputable institutional investor like FMR LLC is generally a neutral to slightly positive signal, as it implies a degree of confidence in the company, even if the investment is passive. There are no negative financial or operational details in this type of filing.
Positives
- A major institutional investor like FMR LLC taking a significant stake can signal confidence in the company's long-term prospects.
- The acquisition is stated to be in the ordinary course of business, indicating a passive investment rather than an activist intent to change control.
Future Outlook
NA
Management Comments
- The reporting persons certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
FMR LLC is a major global asset management firm, and its disclosure of a significant stake in Jade Biosciences Inc. indicates its investment interest in the biotechnology or life sciences sector, depending on Jade Biosciences' specific business. Such an investment by a prominent institutional player can sometimes be viewed positively by the market, suggesting a vote of confidence in the company or its industry segment.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake might increase investor confidence and potentially attract more institutional interest, which could positively influence share price.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where the Power of Attorney (accession number: -23-000003) was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Stephanie J. Brown on behalf of Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where the Power of Attorney (accession number: -23-000038) for Abigail P. Johnson was incorporated by reference. |
| 2025-05-30 | Date of event which required the filing of this statement (ownership threshold crossed/changed). |
| 2025-06-05 | Date of filing/signature of the Schedule 13G. |
Keywords
Jade Biosciences Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Disclosure, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.